Published reports describe semaglutide-associated delayed gastric emptying with resultant regurgitation, silent micro-aspiration, and, in isolated cases, organizing pneumonia
studies have shown a significant portion of patients lose less than 5% of their body weight on the drug, though they may experience other metabolic improvements
Cacciatore, I., Cornacchia, C., Pinnen, F., Mollica, A
Over time, effective management of antipsychotic-associated weight gain with GLP-1 therapy may lead to improved energy, physical functioning, and self-esteem
The generational breakdown of respondents was as follows: Gen Z (13%), millennials (42%), Gen X (34%), and baby boomers (11%)